Glaxo used ghostwriting program to promote Paxil

WASHINGTON - Drugmaker GlaxoSmithKline P.L.C. used a sophisticated ghostwriting program to promote its antidepressant Paxil, letting doctors take credit for medical-journal articles mainly written by company consultants, according to court documents obtained by the Associated Press.

Read More

Copyright PHILY - Philly.com
Contact Us